PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
DarioHealth Corp. (DRIO)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS23725P2092
CUSIP23725P209
SectorHealthcare
IndustryDiagnostics & Research

Highlights

Market Cap$46.59M
EPS-$1.93
PE Ratio191.45
Revenue (TTM)$20.35M
Gross Profit (TTM)$14.01M
EBITDA (TTM)-$51.08M
Year Range$0.68 - $4.58
Target Price$5.67
Short %5.26%
Short Ratio10.31

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


DarioHealth Corp.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in DarioHealth Corp., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%150.00%200.00%250.00%December2024FebruaryMarchAprilMay
-99.96%
226.90%
DRIO (DarioHealth Corp.)
Benchmark (^GSPC)

S&P 500

Returns By Period

DarioHealth Corp. had a return of -8.72% year-to-date (YTD) and -56.99% in the last 12 months. Over the past 10 years, DarioHealth Corp. had an annualized return of -52.39%, while the S&P 500 had an annualized return of 10.64%, indicating that DarioHealth Corp. did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-8.72%7.50%
1 month9.79%-1.61%
6 months17.60%17.65%
1 year-56.99%26.26%
5 years (annualized)-37.76%11.73%
10 years (annualized)-52.39%10.64%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20249.88%7.41%-24.63%-7.19%
2023-60.98%-5.47%42.15%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of DRIO is 21, indicating that it is in the bottom 21% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of DRIO is 2121
DarioHealth Corp.(DRIO)
The Sharpe Ratio Rank of DRIO is 2121Sharpe Ratio Rank
The Sortino Ratio Rank of DRIO is 2525Sortino Ratio Rank
The Omega Ratio Rank of DRIO is 2525Omega Ratio Rank
The Calmar Ratio Rank of DRIO is 1616Calmar Ratio Rank
The Martin Ratio Rank of DRIO is 1818Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for DarioHealth Corp. (DRIO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


DRIO
Sharpe ratio
The chart of Sharpe ratio for DRIO, currently valued at -0.53, compared to the broader market-2.00-1.000.001.002.003.004.00-0.53
Sortino ratio
The chart of Sortino ratio for DRIO, currently valued at -0.39, compared to the broader market-4.00-2.000.002.004.006.00-0.39
Omega ratio
The chart of Omega ratio for DRIO, currently valued at 0.95, compared to the broader market0.501.001.500.95
Calmar ratio
The chart of Calmar ratio for DRIO, currently valued at -0.55, compared to the broader market0.002.004.006.00-0.55
Martin ratio
The chart of Martin ratio for DRIO, currently valued at -1.15, compared to the broader market-10.000.0010.0020.0030.00-1.15
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.17, compared to the broader market-2.00-1.000.001.002.003.004.002.17
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.11, compared to the broader market-4.00-2.000.002.004.006.003.11
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.38, compared to the broader market0.501.001.501.38
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.65, compared to the broader market0.002.004.006.001.65
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.41, compared to the broader market-10.000.0010.0020.0030.008.41

Sharpe Ratio

The current DarioHealth Corp. Sharpe ratio is -0.53. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of DarioHealth Corp. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchAprilMay
-0.53
2.17
DRIO (DarioHealth Corp.)
Benchmark (^GSPC)

Dividends

Dividend History


DarioHealth Corp. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2024FebruaryMarchAprilMay
-99.97%
-2.41%
DRIO (DarioHealth Corp.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the DarioHealth Corp.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the DarioHealth Corp. was 99.98%, occurring on Nov 22, 2023. The portfolio has not yet recovered.

The current DarioHealth Corp. drawdown is 99.97%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.98%May 14, 20132652Nov 22, 2023
-13.79%Apr 29, 20136May 6, 20135May 13, 201311
-11.97%Apr 18, 20133Apr 22, 20134Apr 26, 20137
-3.57%Apr 16, 20131Apr 16, 20131Apr 17, 20132

Volatility

Volatility Chart

The current DarioHealth Corp. volatility is 31.07%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%December2024FebruaryMarchAprilMay
31.07%
4.10%
DRIO (DarioHealth Corp.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of DarioHealth Corp. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items